Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure?

scientific article

Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.SURG.2018.01.004
P698PubMed publication ID29455841

P50authorBas Groot KoerkampQ88511943
Ronald P DeMatteoQ89998373
P2093author name stringMithat Gonen
Vinod P Balachandran
Peter J Allen
Michael I D'Angelica
T Peter Kingham
William R Jarnagin
Eran Sadot
Joanne F Chou
Nancy E Kemeny
Leslie H Blumgart
John M Creasy
P2860cites workFive-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741Q33383727
What defines 'cure' after liver resection for colorectal metastases? Results after 10 years of follow-up.Q33865014
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive casesQ33874670
Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring systemQ34259566
Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimenQ34505635
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancerQ34506398
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study GroupQ34511070
Trends in long-term survival following liver resection for hepatic colorectal metastasesQ34523502
Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single centerQ34608477
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trialQ34656647
Actual 10-year survival after resection of colorectal liver metastases defines cure.Q34699863
Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastasesQ35012020
Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate?Q35942654
BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection.Q36086837
Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive casesQ36174825
smcure: an R-package for estimating semiparametric mixture cure modelsQ36389058
Recurrence After Partial Hepatectomy for Metastatic Colorectal Cancer: Potentially Curative Role of Salvage Repeat ResectionQ36657953
Cure models as a useful statistical tool for analyzing survivalQ37096671
Prognostic significance of early recurrence: a conditional survival analysis in patients with resected colorectal liver metastasisQ37216663
Effect on outcome of recurrence patterns after hepatectomy for colorectal metastasesQ37806160
Insights from mixture cure modeling of molecular markers for prognosis in breast cancerQ38102971
Repeat resection leads to long-term survival: analysis of 10-year follow-up of patients with colorectal liver metastasesQ38506108
Hepatic resection for metastatic colorectal cancer results in cure for some patientsQ41479460
Estimation in a Cox proportional hazards cure modelQ41732626
Semi-parametric estimation in failure time mixture modelsQ46555158
Parenchymal-Sparing Hepatectomy Does Not Increase Intrahepatic Recurrence in Patients with Advanced Colorectal Liver MetastasesQ47791805
Cure model survival analysis after hepatic resection for colorectal liver metastasesQ56971428
Survival after Hepatic Resection for Metastatic Colorectal Cancer: Trends in Outcomes for 1,600 Patients during Two Decades at a Single InstitutionQ57845858
Long-term hepatic arterial infusion chemotherapy. Anatomic considerations, operative technique, and treatment morbidityQ70366970
Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de ChirurgieQ71018196
Phase I clinical and pharmacokinetic study of irinotecan, fluorouracil, and leucovorin in patients with advanced solid tumorsQ71778659
Ninety-six five-year survivors after liver resection for metastatic colorectal cancerQ73954807
Hepatic resection for colorectal metastases: value for risk scoring systems?Q80713651
Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidityQ81234867
P407language of work or nameEnglishQ1860
P577publication date2018-02-15
P1433published inSurgeryQ15731526
P1476titleActual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure?

Reverse relations

cites work (P2860)
Q64890701Analysis of Prognostic Factors for Resected Synchronous and Metachronous Liver Metastases from Colorectal Cancer.
Q59811881Current status of surgical treatment of colorectal liver metastases
Q89839458Effect of Time to Surgery of Colorectal Liver Metastases on Survival
Q58545485Identification of Actual 10-Year Survival After Hepatectomy of HBV-Related Hepatocellular Carcinoma: a Multicenter Study
Q91870143Modernizing the clinical risk score to more accurately predict survival following resection of colorectal liver metastases
Q98289686Photothermal therapy technology of metastatic colorectal cancer
Q91971330Prognostic value of sarcopenia in patients with colorectal liver metastases undergoing hepatic resection
Q58695102Proposal of Two Prognostic Models for the Prediction of 10-Year Survival after Liver Resection for Colorectal Metastases
Q90369851Variation in the Use of Resection for Colorectal Cancer Liver Metastases

Search more.